GL1X · GenesisL1 explorer

MolNFT v1 · #21654 · protein

Peptide inhibitors of src SH3-SH2-phosphoprotein interactions

1SHD · C-src tyrosine kinase SH2 domain: “Peptide inhibitors of src SH3-SH2-phosphoprotein interactions”. X-ray diffraction, 1 ligand (ACE). MolNFT v1 #21654 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1SHD
Type
protein
Length
105 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
C-src tyrosine kinase SH2 domain; Trka receptor
UniProt
P12931
Ligands
ACE

Structure

x-ray diffraction · 2 distinct chains · 20% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AC-src tyrosine kinase SH2 domainprotein10121% helix, 32% strandP12931
BTrka receptorprotein40% helix, 0% strand—

Ligands and binding sites

  • ACE · Acetyl group · ligand · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Interfaces

1 interface between chains.

  • A–B · 447 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 modified (covalent ligand, phosphorylation).

Compared structures

  • 1SHD · Peptide inhibitors of src SH3-SH2-phosphoprotein interactions · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.